Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
9.69
-0.10 (-1.02%)
Nov 21, 2024, 4:00 PM EST - Market closed
Neumora Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Net Income | -293.7 | -235.93 | -130.9 | -237.31 | -99.27 | -0.25 |
| Depreciation & Amortization | 0.64 | 0.67 | 0.59 | 0.54 | 0.11 | - |
| Asset Writedown & Restructuring Costs | 63.9 | 63.9 | 13 | 157 | 69.86 | - |
| Loss (Gain) From Sale of Investments | -5.31 | -3.74 | -0.73 | - | - | - |
| Stock-Based Compensation | 36.14 | 17.24 | 8.3 | 4.27 | 1.68 | - |
| Other Operating Activities | 3.41 | 3.48 | 1.79 | 1.04 | 3.99 | - |
| Change in Accounts Payable | 3.86 | -0.58 | -1.25 | -0.76 | -4.67 | - |
| Change in Other Net Operating Assets | 7.02 | -8.32 | -5.7 | -0.2 | 1.55 | 0.25 |
| Operating Cash Flow | -184.04 | -163.28 | -114.9 | -75.42 | -26.76 | - |
| Capital Expenditures | -0.82 | -0.12 | -0.51 | -0.82 | -1.3 | - |
| Cash Acquisitions | - | - | - | - | 2.81 | - |
| Sale (Purchase) of Intangibles | -4.59 | -4.59 | -13 | - | - | - |
| Investment in Securities | 47.33 | 69.09 | -154.5 | - | - | - |
| Other Investing Activities | - | - | - | - | -12.75 | - |
| Investing Cash Flow | 41.92 | 64.39 | -168.01 | -0.82 | -11.24 | - |
| Long-Term Debt Issued | - | - | - | - | 55.91 | - |
| Net Debt Issued (Repaid) | - | - | - | - | 55.91 | - |
| Issuance of Common Stock | 6.59 | 236.23 | 2.66 | 3.47 | 3.19 | - |
| Repurchase of Common Stock | - | -0.49 | - | - | -0 | - |
| Other Financing Activities | -1.05 | -3.8 | -0.92 | -1.21 | -0.9 | - |
| Financing Cash Flow | 5.55 | 231.94 | 115.74 | 293.51 | 230.1 | - |
| Net Cash Flow | -136.57 | 133.05 | -167.17 | 217.27 | 192.1 | - |
| Free Cash Flow | -184.86 | -163.4 | -115.41 | -76.24 | -28.06 | - |
| Free Cash Flow Per Share | -1.17 | -2.51 | -4.24 | -3.48 | -2.16 | - |
| Levered Free Cash Flow | -113.14 | -111.24 | -93.02 | -37.08 | - | - |
| Unlevered Free Cash Flow | -113.14 | -111.24 | -93.02 | -37.08 | - | - |
| Change in Net Working Capital | -12.14 | 6.82 | 11.61 | -9.12 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.